FILIERI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 1.096
EU - Europa 301
AS - Asia 295
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.710
Nazione #
US - Stati Uniti d'America 1.093
CN - Cina 136
SG - Singapore 105
UA - Ucraina 79
DE - Germania 74
TR - Turchia 50
IT - Italia 45
FI - Finlandia 37
GB - Regno Unito 27
SE - Svezia 21
BR - Brasile 16
RU - Federazione Russa 5
BE - Belgio 4
CA - Canada 3
IQ - Iraq 3
NL - Olanda 3
AT - Austria 2
FR - Francia 2
LT - Lituania 2
EC - Ecuador 1
EU - Europa 1
LK - Sri Lanka 1
Totale 1.710
Città #
Woodbridge 158
Chandler 116
Jacksonville 90
Fairfield 87
Ashburn 85
Singapore 82
Santa Clara 80
Houston 60
Ann Arbor 48
Wilmington 43
Seattle 42
Nanjing 34
Cambridge 33
Izmir 26
Shanghai 22
Ferrara 21
Helsinki 19
Addison 18
Princeton 18
Dearborn 16
Boardman 14
Milan 10
Bremen 9
New York 9
Hebei 8
Shenyang 8
Beijing 7
Changsha 7
Jinan 6
San Diego 5
Brussels 4
Mountain View 4
Nanchang 4
Ningbo 4
Padova 4
Tappahannock 4
Tianjin 4
Auburn Hills 3
Falls Church 3
Frankfurt am Main 3
Hefei 3
Indiana 3
Jiaxing 3
Kunming 3
Los Angeles 3
Toronto 3
Baghdad 2
Chengdu 2
Falkenstein 2
Guangzhou 2
Orange 2
Washington 2
Alvorada 1
Augusta 1
Balsas 1
Baotou 1
Belo Horizonte 1
Bodio Lomnago 1
Changchun 1
Colombo 1
Flores 1
Guarulhos 1
Haikou 1
Huzhou 1
Istanbul 1
Kilburn 1
Lanzhou 1
Navegantes 1
Nova Serrana 1
Osasco 1
Peschiera del Garda 1
Pitimbu 1
Quito 1
Redwood City 1
Rio de Janeiro 1
Rolim de Moura 1
Rome 1
San Francisco 1
San Mateo 1
Sete Lagoas 1
Shaoxing 1
Shenzhen 1
São José do Rio Preto 1
São Miguel do Fidalgo 1
São Pedro da Aldeia 1
Taizhou 1
Tomsk 1
Yellow Springs 1
Yinchuan 1
Totale 1.285
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 176
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 163
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 127
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 123
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 108
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 106
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 98
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 84
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 83
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 80
A new VHL polymorphism in a big family from Ferrara 80
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 80
Real-time PCR is useful to detect menin gene deletions 77
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 70
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 65
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 59
null 44
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  30
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 30
Totale 1.723
Categoria #
all - tutte 8.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 0 0 16 27 2 5
2020/2021206 16 26 27 37 2 19 9 21 4 19 22 4
2021/2022177 5 24 10 3 7 7 7 4 3 16 23 68
2022/2023222 22 27 12 29 38 29 10 16 25 1 6 7
2023/2024135 13 9 5 4 11 21 10 25 8 1 2 26
2024/2025263 10 2 39 9 57 87 7 9 43 0 0 0
Totale 1.723